Diplomat Pharmacy (DPLO) Tops Q1 EPS by 4c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Diplomat Pharmacy (DPLO) PT Raised to $20 at Barclays; '1Q17 Beat & Maintain, Acquisition Expands Manufacturer Services'
May 9, 2017 12:50 PM EDTBarclays raised its price target on Diplomat Pharmacy (NYSE: DPLO) to $20.00 (from $17.00) while maintaining a Overweight rating, following the company's first quarter earnings report.
Analyst Eric Percher notes the company reported first quarter earnings per share above consensus and offered in-line revenue... More
Diplomat Pharmacy (DPLO) PT Raised to $17 at Cowen; Reiterates Market Perform
May 9, 2017 8:11 AM EDTCowen raised its price target on Diplomat Pharmacy (NYSE: DPLO) to $17.00 (from $12.00) while maintaining a Market Perform rating. DPLO reported 1Q revenues of $1.08B, which was in-line with consensus, due to acquisitions, manufacturing price increases and contributions from new drugs. Adjusted EPS of $0.19 also exceeded... More



